Clinical Pharmacokinetics of Octreotide
- 1 November 1993
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 25 (5) , 375-391
Abstract
Among somatostatin analogues, octreotide is the most extensively studied. Its pharmacodynamic properties are similar to those of somatostatin, with a wide spectrum of inhibitory effects on anterior...Keywords
This publication has 98 references indexed in Scilit:
- Short-Term Continuous Infusion of Octreotide in AcromegalyHormone and Metabolic Research, 1991
- PHARMACOKINETICS OF THE LONG‐ACTING SOMATOSTATIN ANALOGUE OCTREOTIDE (SMS 201‐995) IN ACROMEGALYClinical Endocrinology, 1990
- AcromegalyNew England Journal of Medicine, 1990
- Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patientsJournal of Neurosurgery, 1988
- The effect of a long‐acting somatostatin analogue (SMS 201–995) on intermediary metabolism and gut hormones after a test meal in normal subjectsAlimentary Pharmacology & Therapeutics, 1987
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Visual Improvement with SMS 201–995 in a Patient with a Thyrotropin-Secreting Pituitary AdenomaNew England Journal of Medicine, 1987
- Effect of the Somatostatin Analogue Sandostatin (SMS 201–995) on Gastrointestinal, Pancreatic and Biliary Function and Hormone Release in Normal MenDigestion, 1987
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985